Align Technology, Inc. logo
Align Technology, Inc. (ALGN)
Compare

Align Technology, Inc. (ALGN) Free Cash Flow Yield: 5.45%

Is Align Technology, Inc.’s free cash flow yield high or low?

Align Technology, Inc.'s free cash flow yield of 5.45% is 79% above its 5-year average of 3.04%, around the middle of its 5-year range (0.98%–7.49%).

The free cash flow yield for Align Technology, Inc. (ALGN) is 5.45% as of Wednesday, June 10, 2026. It is above its 12-month average by 0.76% (5.41%).

ALGN Free Cash Flow Yield Chart

ALGN Free Cash Flow Yield
5.45%+19.52% 1Y
Zoom

ALGN Average Free Cash Flow Yield Chart

ALGN Current vs Average Free Cash Flow Yield Chart

ALGN Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

5.45%

FREE CASH FLOW YIELD AVG TTM

5.41%

FREE CASH FLOW YIELD AVG 3Y

3.77%

FREE CASH FLOW YIELD AVG 5Y

3.04%

FREE CASH FLOW YIELD AVG 10Y

2.40%

FREE CASH FLOW YIELD AVG 15Y

2.94%

FREE CASH FLOW YIELD AVG 20Y

3.38%

CURRENT VS TTM AVG

+0.76%

CURRENT VS 3Y AVG

+44.58%

CURRENT VS 5Y AVG

+79.13%

CURRENT VS 10Y AVG

+126.96%

CURRENT VS 15Y AVG

+85.31%

CURRENT VS 20Y AVG

+61.14%

ALGN Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
Align Technology, Inc. (ALGN)$12.56B5.45%5.41%3.77%3.04%
Baxter International Inc. (BAX)$10.49B6.83%3.14%3.91%3.73%
Charles River Laboratories International, Inc. (CRL)$9.06B4.25%6.31%5.03%4.14%
Hologic, Inc. (HOLX)$16.97B5.82%6.30%5.70%7.89%
Bio-Rad Laboratories, Inc. (BIO)$7.89B4.54%4.53%3.11%2.78%
Moderna, Inc. (MRNA)$18.40BN/A8.49%9.09%9.09%
Hims & Hers Health, Inc. (HIMS)$6.42B1.15%1.43%1.61%1.61%
BioNTech SE (BNTX)$21.81B6.86%3.80%18.89%19.80%
Mettler-Toledo International Inc. (MTD)$22.85B3.46%3.21%3.24%2.88%
Waters Corporation (WAT)$23.83B0.88%2.83%2.68%2.70%

Yield Comparison

FCF Yield

5.45%

Earnings Yield

3.39%

Dividend Yield

N/A

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Align Technology, Inc. Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Align Technology, Inc. Free Cash Flow Yield FAQ

What is the free cash flow yield for Align Technology, Inc. (ALGN)?
The free cash flow yield for ALGN stock is 5.45%.
Is Align Technology, Inc.'s free cash flow yield high or low?
Align Technology, Inc.'s free cash flow yield of 5.45% is 79% above its 5-year average of 3.04%, around the middle of its 5-year range (0.98%–7.49%).
What is the TTM average free cash flow yield for Align Technology, Inc. (ALGN)?
The TTM average free cash flow yield for ALGN stock is 5.41%.
What is the 3Y average free cash flow yield for Align Technology, Inc. (ALGN)?
The 3Y average free cash flow yield for ALGN stock is 3.77%.
What is the 5Y average free cash flow yield for Align Technology, Inc. (ALGN)?
The 5Y average free cash flow yield for ALGN stock is 3.04%.
What is the 10Y average free cash flow yield for Align Technology, Inc. (ALGN)?
The 10Y average free cash flow yield for ALGN stock is 2.40%.
What is the 15Y average free cash flow yield for Align Technology, Inc. (ALGN)?
The 15Y average free cash flow yield for ALGN stock is 2.94%.
What is the 20Y average free cash flow yield for Align Technology, Inc. (ALGN)?
The 20Y average free cash flow yield for ALGN stock is 3.38%.

Align Technology, Inc. Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-105.45%
2026-06-095.38%
2026-06-085.57%
2026-06-055.71%
2026-06-045.69%
2026-06-035.92%
2026-06-025.75%
2026-06-015.64%
2026-05-295.48%
2026-05-285.53%
2026-05-275.88%
2026-05-265.86%
2026-05-225.85%
2026-05-215.88%
2026-05-205.87%
2026-05-196.17%
2026-05-186.04%
2026-05-156.09%
2026-05-145.97%
2026-05-135.92%
2026-05-125.78%
2026-05-115.82%
2026-05-085.68%
2026-05-075.69%
2026-05-065.51%
2026-05-054.90%
2026-05-044.81%
2026-05-014.62%
2026-04-304.70%
2026-04-294.63%
2026-04-284.66%
2026-04-274.48%
2026-04-244.36%
2026-04-234.34%
2026-04-224.22%
2026-04-214.24%
2026-04-204.31%
2026-04-174.35%
2026-04-164.47%
2026-04-154.43%
2026-04-144.48%
2026-04-134.58%
2026-04-104.78%
2026-04-094.74%
2026-04-084.68%
2026-04-074.96%
2026-04-064.81%
2026-04-024.84%
2026-04-014.79%
2026-03-314.82%
2026-03-304.97%
2026-03-274.97%
2026-03-264.66%
2026-03-254.59%
2026-03-244.61%
2026-03-234.57%
2026-03-204.77%
2026-03-194.69%
2026-03-184.80%
2026-03-174.69%
2026-03-164.88%
2026-03-135.03%
2026-03-124.95%
2026-03-114.73%
2026-03-104.88%
2026-03-094.72%
2026-03-064.75%
2026-03-054.71%
2026-03-044.54%
2026-03-034.53%
2026-03-024.37%
2026-02-274.35%
2026-02-264.14%
2026-02-254.16%
2026-02-244.22%
2026-02-234.32%
2026-02-204.12%
2026-02-194.13%
2026-02-184.10%
2026-02-174.18%
2026-02-134.19%
2026-02-124.26%
2026-02-113.96%
2026-02-103.99%
2026-02-094.07%
2026-02-064.17%
2026-02-054.45%
2026-02-044.85%
2026-02-034.98%
2026-02-024.78%
2026-01-304.80%
2026-01-294.77%
2026-01-284.74%
2026-01-274.68%
2026-01-264.67%
2026-01-234.64%
2026-01-224.63%
2026-01-214.60%
2026-01-204.73%
2026-01-164.56%
2026-01-154.56%
2026-01-144.62%
2026-01-134.60%
2026-01-124.55%
2026-01-094.53%
2026-01-084.59%
2026-01-074.69%
2026-01-064.67%
2026-01-054.89%
2026-01-025.02%
2025-12-315.01%
2025-12-304.95%
2025-12-294.96%
2025-12-264.94%
2025-12-244.96%
2025-12-234.99%
2025-12-224.91%
2025-12-194.96%
2025-12-184.85%
2025-12-174.87%
2025-12-164.80%
2025-12-154.81%
2025-12-124.73%
2025-12-114.78%
2025-12-104.76%
2025-12-094.92%
2025-12-084.96%
2025-12-054.98%
2025-12-044.99%
2025-12-035.05%
2025-12-025.18%
2025-12-015.33%
2025-11-285.32%
2025-11-265.31%
2025-11-255.31%
2025-11-245.45%
2025-11-215.49%
2025-11-205.89%
2025-11-195.85%
2025-11-185.91%
2025-11-175.90%
2025-11-145.70%
2025-11-135.61%
2025-11-125.52%
2025-11-115.41%
2025-11-105.66%
2025-11-075.80%
2025-11-065.85%
2025-11-055.70%
2025-11-046.89%
2025-11-036.74%
2025-10-316.78%
2025-10-306.75%
2025-10-297.08%
2025-10-287.02%
2025-10-276.89%
2025-10-246.91%
2025-10-236.87%
2025-10-226.89%
2025-10-216.86%
2025-10-206.93%
2025-10-177.16%
2025-10-167.19%
2025-10-157.28%
2025-10-147.20%
2025-10-137.22%
2025-10-107.43%
2025-10-097.09%
2025-10-087.02%
2025-10-077.16%
2025-10-067.11%
2025-10-037.07%
2025-10-027.26%
2025-10-017.33%
2025-09-307.46%
2025-09-297.40%
2025-09-267.40%
2025-09-257.49%
2025-09-247.29%
2025-09-237.24%
2025-09-227.12%
2025-09-197.11%
2025-09-187.05%
2025-09-177.22%
2025-09-167.09%
2025-09-157.13%
2025-09-127.10%
2025-09-116.87%
2025-09-107.03%
2025-09-096.87%
2025-09-086.83%
2025-09-056.72%
2025-09-046.93%
2025-09-037.06%
2025-09-026.81%
2025-08-296.58%
2025-08-286.62%
2025-08-276.58%
2025-08-266.59%
2025-08-256.45%
2025-08-226.25%
2025-08-216.64%
2025-08-206.51%
2025-08-196.50%
2025-08-186.45%
2025-08-156.56%
2025-08-146.54%
2025-08-136.41%
2025-08-126.65%
2025-08-116.93%
2025-08-086.68%
2025-08-076.73%
2025-08-066.83%
2025-08-056.13%
2025-08-046.22%
2025-08-016.28%
2025-07-316.64%
2025-07-304.21%
2025-07-294.16%
2025-07-284.14%
2025-07-254.17%
2025-07-244.24%
2025-07-234.20%
2025-07-224.42%
2025-07-214.53%
2025-07-184.49%
2025-07-174.46%
2025-07-164.50%
2025-07-154.44%
2025-07-144.30%
2025-07-114.24%
2025-07-104.19%
2025-07-094.27%
2025-07-084.38%
2025-07-074.42%
2025-07-034.35%
2025-07-024.35%
2025-07-014.41%
2025-06-304.52%
2025-06-274.55%
2025-06-264.56%
2025-06-254.58%
2025-06-244.59%
2025-06-234.67%
2025-06-204.71%
2025-06-184.76%
2025-06-174.89%
2025-06-164.69%
2025-06-134.82%
2025-06-124.71%
2025-06-114.62%
2025-06-104.56%
2025-06-094.73%
2025-06-064.74%
2025-06-054.75%
2025-06-044.76%
2025-06-034.78%
2025-06-024.80%
2025-05-304.73%
2025-05-294.68%

Showing the most recent 260 of 4,678 data points. The chart above shows the full history.

About Align Technology, Inc.

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

Tempe, AZ
21,200 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Joseph Hogan